CellWell record HH-345579
Small, dense LDL-C as a predictor of cardiovascular risk and benefit of alirocumab in patients with recent acute coronary syndrome receiving optimized statin treatment
Gregory G Schwartz; Michael Szarek; Christa M Cobbaert; L Renee Ruhaak; Markus Schwertfeger; Deepak L Bhatt; Vera A Bittner; Shaun G Goodman; Robert A Harrington; Irena Stevanovic; Hagai Tavori; Esther Reijnders; Fred Romijn; Nicolaas J M van Neer; Harvey D White; J W Jukema; P Gabriel Steg
2026
In plain language
Small dense LDL cholesterol and standard LDL similarly predicted cardiovascular risk and treatment response to PCSK9 inhibitor in acute coronary syndrome.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-345579
Produced by the CellWell Research Engine, custom software owned and operated by CellWell. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.